Loading clinical trials...
Loading clinical trials...
A Phase I Study of Avelumab, Palbociclib, and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Conditions
Interventions
Avelumab
Palbociclib
+1 more
Locations
1
United States
UC San Diego Moores Cancer Center
La Jolla, California, United States
Start Date
June 6, 2018
Primary Completion Date
February 4, 2020
Completion Date
December 30, 2025
Last Updated
April 3, 2025
NCT05039801
NCT06980038
NCT06806852
NCT05526924
NCT05977907
NCT02734537
Lead Sponsor
Kathryn Gold
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions